-
FROM BROAD LUNG CANCER ICD-10 CODES TO CONFIRMED NON-SMALL CELL LUNG CANCER (NSCLC): HUMAN-IN-THE-LOOP LARGE LANGUAGE MODEL (LLM) EXTRACTED CLINICAL NOTES ENABLE HISTOLOGY AND STAGE STRATIFICATION NOT ACHIEVABLE FROM STRUCTURED DATA ALONE USING...
Aug 11, 2026, 17:16 PM -
ARTIFICIAL INTELLIGENCE FOR DATA EXTRACTION IN LIVE HEOR LITERATURE REVIEWS: A REAL-WORLD ANALYSIS ACROSS MORE THAN 20 REVIEWS
Aug 11, 2026, 17:16 PM -
ASSOCIATION BETWEEN ACUPUNCTURE TREATMENT EXPOSURE AND ISCHEMIC STROKE INCIDENCE IN PATIENTS WITH ATRIAL FIBRILLATION: A NATIONWIDE RETROSPECTIVE COHORT STUDY IN KOREA
Aug 11, 2026, 17:16 PM -
INTEGRATING PATIENT-CENTRICITY INTO REAL-WORLD EVIDENCE GENERATION: INSIGHTS FROM SOCIAL MEDIA LISTENING
Aug 11, 2026, 17:16 PM -
COST-BENEFIT ANALYSIS OF INCREASING POPULATION PHYSICAL ACTIVITY FOR CARDIOMETABOLIC DISEASE PREVENTION IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
COST EFFECTIVENESS AND HEALTH CARE RESOURCE UTILIZATION OF PRE-EMPTIVE USE OF TIPS WITH CONTROLLED EXPANSION FOR HIGH-RISK PATIENTS WITH VARICEAL BLEEDING IN ITALY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF A NATIONAL LOW-DOSE COMPUTED TOMOGRAPHY (LDCT) LUNG CANCER SCREENING PROGRAM IN IRAQ: ECONOMIC EVALUATION USING LOCAL ADAPTATION OF GLOBAL MODELS
Aug 11, 2026, 17:16 PM -
DRUG PRICING AND HTA IN EUROPE: A COMPARATIVE ANALYSIS OF EU AND WESTERN BALKAN REGULATORY PATHWAYS
Aug 11, 2026, 17:16 PM -
RARE BUT COSTLY: PREVALENCE AND DIRECT MEDICAL COSTS OF 15 RARE DISEASES AMONG DAMAN BENEFICIARIES IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
ASSESSMENT OF SURROGATE ENDPOINTS IN EU4 + UK HTA DECISION-MAKING FOR ANTIBODY-DRUG CONJUGATES IN BREAST CANCER
Aug 11, 2026, 17:16 PM -
PROJECTED HEALTH OUTCOMES AND RESOURCE USE: IMPACT OF INTRODUCING PEMBROLIZUMAB (INCLUDING INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION) IN EARLY-STAGE HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) IN THE U.S. MEDICARE POPULATION
Aug 11, 2026, 17:16 PM -
A BAYESIAN FRAMEWORK FOR NETWORK META-ANALYSIS OF INDIVIDUAL PATIENT DATA SURVIVAL OUTCOMES USING FLEXIBLE PARAMETRIC SURVIVAL MODELS
Aug 11, 2026, 17:16 PM -
TEST, TARGET, TREAT: COST-EFFECTIVENESS OF HSCRP-GUIDED TREATMENT IN PEOPLE WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE IN SWEDEN
Aug 11, 2026, 17:16 PM -
PATIENT INVOLVEMENT IN HTA ACROSS THE EU4 AND UK: A MAPPING OF ACCESS POINTS AND INFLUENCE ACROSS HTA MILESTONES
Aug 11, 2026, 17:16 PM -
STIMULATING CAPACITY BUILDING AT EUROPEAN HTA BODIES: EARLY EXPERIENCE FROM THE SUSTAIN-HTA FELLOWSHIP PROGRAM
Aug 11, 2026, 17:16 PM -
BEYOND THE AGGREGATE RATE: HOW GERMANY'S FORSCHUNGSDATENZENTRUM GESUNDHEIT (FDZ) WILL RESHAPE VACCINATION COVERAGE MONITORING
Aug 11, 2026, 17:16 PM -
TRENDS IN UTILITY VALUES APPLIED IN NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) TECHNOLOGY APPRAISALS FOR NON-SMALL CELL LUNG CANCER (NSCLC)
Aug 11, 2026, 17:16 PM -
ECONOMIC AND OPERATIONAL IMPACT OF A FULLY DIGITAL DIAGNOSTIC PATHWAY FOR OBSTRUCTIVE SLEEP APNOEA IN THE NHS: A TIME-DRIVEN ACTIVITY-BASED COSTING ANALYSIS
Aug 11, 2026, 17:16 PM -
A SIMPLIFIED TREATMENT-SEQUENCE MODELING APPROACH FOR EARLY ONCOLOGY DECISION SUPPORT USING LIMITED SURVIVAL DATA: A CASE STUDY IN FAVORABLE-RISK ADVANCED RENAL CELL CARCINOMA
Aug 11, 2026, 17:16 PM -
DISTRIBUTION OF PHARMACEUTICALS REIMBURSED AT A 100% RATE BY ANATOMICAL THERAPEUTIC CHEMICAL (ATC) GROUP IN ESTONIA, 2023-2026: AN ANALYSIS USING ESTONIAN HEALTH INSURANCE FUND (EHIF) DATA
Aug 11, 2026, 17:16 PM
